Black Rock Inc. Coherus Bio Sciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,752,500 shares of CHRS stock, worth $9.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,752,500

Previous 11,230,522 4.65%

Holding current value

$9.05 Million

Previous $26.8 Million 24.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.58 - $2.51 $824,725 - $1.31 Million	521,978 Added 4.65%	11,752,500 $20.3 Million
Q1 2024 May 10, 2024	SELL	$2.02 - $3.14 $1.71 Million - $2.65 Million	-844,173 Reduced 6.99%	11,230,522 $26.8 Million
Q4 2023 Feb 13, 2024	BUY	$1.59 - $3.85 $678,923 - $1.64 Million	426,996 Added 3.67%	12,074,695 $40.2 Million
Q3 2023 Nov 13, 2023	SELL	$3.74 - $5.45 $15.5 Million - $22.6 Million	-4,139,439 Reduced 26.22%	11,647,699 $43.6 Million
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $5.27 Million - $11.5 Million	1,389,573 Added 9.65%	15,787,138 $67.4 Million
Q1 2023 May 12, 2023	BUY	$5.89 - $10.52 $1.86 Million - $3.32 Million	315,269 Added 2.24%	14,397,565 $98.5 Million
Q4 2022 Feb 13, 2023	BUY	$5.69 - $10.07 $6.24 Million - $11.1 Million	1,097,453 Added 8.45%	14,082,296 $112 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $726,701 - $1.41 Million	101,353 Added 0.79%	12,984,843 $125 Million
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $4.75 Million - $10.7 Million	811,303 Added 6.72%	12,883,490 $93.3 Million
Q1 2022 May 12, 2022	BUY	$10.92 - $16.41 $1.67 Million - $2.52 Million	153,332 Added 1.29%	12,072,187 $156 Million
Q4 2021 Feb 10, 2022	BUY	$15.81 - $18.99 $5.2 Million - $6.25 Million	329,012 Added 2.84%	11,918,855 $190 Million
Q3 2021 Nov 09, 2021	SELL	$12.68 - $17.79 $5.46 Million - $7.66 Million	-430,614 Reduced 3.58%	11,589,843 $186 Million
Q2 2021 Aug 11, 2021	BUY	$12.95 - $15.41 $156 Million - $185 Million	12,020,457 New	12,020,457 $166 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

78.3M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $59.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account